ARMATA PHARMACEUTICALS, INC. Depreciation
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Depreciation of $500.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-06-30 was $500.00K, a 66.67% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-03-31 was $457.00K, a 21.22% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-12-31 was $431.00K, a 1.41% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-09-30 was $400.00K, a 33.33% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. depreciation for fiscal 2025 was $1.53M, a 15.55% increase from fiscal 2024.
- ARMATA PHARMACEUTICALS, INC. depreciation for fiscal 2024 was $1.32M, a 32.50% increase from fiscal 2023.
- ARMATA PHARMACEUTICALS, INC. depreciation for fiscal 2023 was $1.00M, a 11.11% increase from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $900.00K, a 23.01% decline from fiscal 2021.
| Period end | Depreciation 1 month | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $500.00K 10-Q · filed 2026-08-12 | $1.05M 10-Q · filed 2026-08-12 | $1.39M derived: sum of 3 quarters · filed 2026-08-12 | $1.79M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2026-03-31 | $457.00K 10-Q · filed 2026-05-13 | $888.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.29M derived: sum of 3 quarters · filed 2026-05-13 | $1.59M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-12-31 | $431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $831.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.13M derived: sum of 3 quarters · filed 2026-08-12 | $1.53M 10-K · filed 2026-03-25 | |||||
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-12 | $700.00K derived: sum of 2 quarters · filed 2026-08-12 | $1.10M 10-Q · filed 2025-11-12 | $1.50M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-06-30 | $300.00K 10-Q · filed 2025-08-12 | $300.00K 10-Q · filed 2026-08-12 | $743.00K 10-Q · filed 2026-08-12 | $700.00K 10-Q · filed 2025-08-12 | $1.10M derived: sum of 3 quarters · filed 2026-08-12 | $1.40M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $377.00K 10-Q · filed 2026-05-13 | $400.00K 10-Q · filed 2025-05-14 | $802.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.10M derived: sum of 3 quarters · filed 2026-05-13 | $1.40M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $725.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.02M derived: sum of 3 quarters · filed 2026-03-25 | $1.32M 10-K · filed 2026-03-25 | $1.30M 10-K · filed 2025-03-21 | ||||
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-12 | $600.00K derived: sum of 2 quarters · filed 2025-11-12 | $900.00K 10-Q · filed 2025-11-12 | $1.20M derived: sum of 4 quarters · filed 2025-11-12 | |||||
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-12 | $600.00K 10-Q · filed 2025-08-12 | $900.00K derived: sum of 3 quarters · filed 2025-08-12 | $1.10M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-14 | $600.00K derived: sum of 2 quarters · filed 2025-05-14 | $800.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.00M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $500.00K derived: sum of 2 quarters · filed 2025-03-21 | $700.00K derived: sum of 3 quarters · filed 2025-03-21 | $1.00M 10-K · filed 2025-03-21 | |||||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-13 | $400.00K derived: sum of 2 quarters · filed 2024-11-13 | $700.00K 10-Q · filed 2024-11-13 | $900.00K derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-13 | $500.00K 10-Q · filed 2024-08-13 | $458.00K 10-Q · filed 2023-08-14 | $700.00K derived: sum of 3 quarters · filed 2024-08-13 | $900.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-07 | $230.00K 10-Q · filed 2023-05-11 | $500.00K derived: sum of 2 quarters · filed 2024-05-07 | $700.00K derived: sum of 3 quarters · filed 2024-05-07 | $900.00K derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $500.00K derived: sum of 2 quarters · filed 2024-03-21 | $700.00K derived: sum of 3 quarters · filed 2024-03-21 | $900.00K 10-K · filed 2024-03-21 | $892.00K 10-K · filed 2023-03-16 | ||||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-14 | $400.00K derived: sum of 2 quarters · filed 2023-11-14 | $600.00K 10-Q · filed 2023-11-14 | $647.00K 10-Q · filed 2022-11-09 | $903.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $200.00K 10-Q · filed 2023-08-14 | $421.00K 10-Q · filed 2023-08-14 | $703.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.00M derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $226.00K 10-Q · filed 2023-05-11 | $503.00K derived: sum of 2 quarters · filed 2023-05-11 | $803.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.10M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $577.00K derived: sum of 2 quarters · filed 2023-03-16 | $877.00K derived: sum of 3 quarters · filed 2023-03-16 | $1.17M 10-K · filed 2023-03-16 | |||||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-09 | $600.00K derived: sum of 2 quarters · filed 2022-11-09 | $892.00K 10-Q · filed 2022-11-09 | $1.16M derived: sum of 4 quarters · filed 2022-11-09 | |||||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-11 | $578.00K 10-Q · filed 2022-08-11 | $855.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.16M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $281.00K 10-Q · filed 2022-05-12 | $555.00K derived: sum of 2 quarters · filed 2022-05-12 | $855.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.16M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $574.00K derived: sum of 2 quarters · filed 2022-03-17 | $874.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.11M 10-K · filed 2022-03-17 | |||||
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-10 | $600.00K derived: sum of 2 quarters · filed 2021-11-10 | $840.00K 10-Q · filed 2021-11-10 | $1.20M derived: sum of 4 quarters · filed 2021-11-10 | |||||
| 2020-06-30 | $300.00K 10-Q · filed 2021-08-12 | $280.00K 10-Q · filed 2020-08-13 | $575.00K 10-Q · filed 2021-08-12 | $897.00K derived: sum of 3 quarters · filed 2021-08-12 | $1.30M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $295.00K 10-Q · filed 2021-05-13 | $597.00K derived: sum of 2 quarters · filed 2021-05-13 | $997.00K derived: sum of 3 quarters · filed 2021-05-13 | $1.33M derived: sum of 4 quarters · filed 2021-05-13 | |||||
| 2019-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $702.00K derived: sum of 2 quarters · filed 2021-03-18 | $1.04M derived: sum of 3 quarters · filed 2021-03-18 | $1.35M 10-K · filed 2021-03-18 | |||||
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-12 | $365.00K 10-Q · filed 2019-11-12 | $735.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.05M 10-Q · filed 2020-11-12 | $1.29M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $335.00K 10-Q · filed 2020-08-13 | $683.00K 10-Q · filed 2020-08-13 | $895.00K derived: sum of 3 quarters · filed 2020-08-13 | $1.23M derived: sum of 4 quarters · filed 2020-08-13 | |||||
| 2019-03-31 | $348.00K 10-Q · filed 2020-05-14 | $100.00K 10-Q · filed 2019-05-06 | $560.00K derived: sum of 2 quarters · filed 2020-05-14 | $896.00K derived: sum of 3 quarters · filed 2020-05-14 | $1.30M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $548.00K derived: sum of 2 quarters · filed 2020-03-19 | $949.00K derived: sum of 3 quarters · filed 2020-03-19 | $1.35M 10-K · filed 2020-03-19 | $358.00K 10-K · filed 2019-03-25 | ||||
| 2018-09-30 | $336.00K 10-Q · filed 2019-11-12 | $737.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.14M 10-Q · filed 2019-11-12 | $268.00K 10-Q · filed 2018-11-08 | $914.00K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $401.00K 10-Q · filed 2019-08-14 | $802.00K 10-Q · filed 2019-08-14 | $178.00K 10-Q · filed 2018-08-09 | $578.00K derived: sum of 3 quarters · filed 2019-08-14 | $663.00K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $89.00K 10-Q · filed 2019-05-06 | $177.00K derived: sum of 2 quarters · filed 2019-05-06 | $262.00K derived: sum of 3 quarters · filed 2019-05-06 | $347.00K derived: sum of 4 quarters · filed 2019-05-06 | |||||
| 2017-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $173.00K derived: sum of 2 quarters · filed 2019-03-25 | $258.00K derived: sum of 3 quarters · filed 2019-03-25 | $343.00K 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $170.00K derived: sum of 2 quarters · filed 2018-11-08 | $255.00K 10-Q · filed 2018-11-08 | $348.00K derived: sum of 4 quarters · filed 2018-11-08 | |||||
| 2017-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $170.00K 10-Q · filed 2018-08-09 | $263.00K derived: sum of 3 quarters · filed 2018-08-09 | $350.00K derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $85.00K 10-Q · filed 2018-05-15 | $178.00K derived: sum of 2 quarters · filed 2018-05-15 | $265.00K derived: sum of 3 quarters · filed 2018-05-15 | $350.00K derived: sum of 4 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $180.00K derived: sum of 2 quarters · filed 2018-03-14 | $265.00K derived: sum of 3 quarters · filed 2018-03-14 | $338.00K 10-K · filed 2018-03-14 | |||||
| 2016-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $172.00K derived: sum of 2 quarters · filed 2017-11-14 | $245.00K 10-Q · filed 2017-11-14 | $327.00K derived: sum of 4 quarters · filed 2017-11-14 | |||||
| 2016-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $158.00K 10-Q · filed 2017-08-14 | $240.00K derived: sum of 3 quarters · filed 2017-08-14 | $340.00K derived: sum of 4 quarters · filed 2017-08-14 | |||||
| 2016-03-31 | $73.00K 10-Q · filed 2017-05-15 | $155.00K derived: sum of 2 quarters · filed 2017-05-15 | $255.00K derived: sum of 3 quarters · filed 2017-05-15 | $314.00K derived: sum of 4 quarters · filed 2017-05-15 | |||||
| 2015-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $182.00K derived: sum of 2 quarters · filed 2017-03-27 | $241.00K derived: sum of 3 quarters · filed 2017-03-27 | $299.00K 10-K · filed 2017-03-27 | |||||
| 2015-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $159.00K derived: sum of 2 quarters · filed 2016-11-10 | $217.00K 10-Q · filed 2016-11-10 | $285.00K derived: sum of 4 quarters · filed 2016-11-10 | |||||
| 2015-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $117.00K 10-Q · filed 2016-08-15 | $185.00K derived: sum of 3 quarters · filed 2016-08-15 | $158.00K derived: sum of 4 quarters · filed 2016-08-15 | |||||
| 2015-03-31 | $58.00K 10-Q · filed 2016-05-12 | $126.00K derived: sum of 2 quarters · filed 2016-05-12 | $99.00K derived: sum of 3 quarters · filed 2016-05-12 | $167.00K derived: sum of 4 quarters · filed 2016-05-12 | |||||
| 2014-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $41.00K derived: sum of 2 quarters · filed 2016-03-30 | $109.00K derived: sum of 3 quarters · filed 2016-03-30 | $127.00K 10-K · filed 2016-03-30 | |||||
| 2014-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $41.00K derived: sum of 2 quarters · filed 2015-11-16 | $59.00K 10-Q · filed 2015-11-16 | $75.00K derived: sum of 4 quarters · filed 2015-11-16 | |||||
| 2014-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $86.00K 10-Q · filed 2015-08-13 | $102.00K derived: sum of 3 quarters · filed 2015-08-13 | $123.00K derived: sum of 4 quarters · filed 2015-08-13 | |||||
| 2014-03-31 | $18.00K 10-Q · filed 2015-05-15 | $34.00K derived: sum of 2 quarters · filed 2015-05-15 | $55.00K derived: sum of 3 quarters · filed 2015-05-15 | $79.00K derived: sum of 4 quarters · filed 2015-05-15 | |||||
| 2013-12-31 | $16.00K derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | $37.00K derived: sum of 2 quarters · filed 2015-04-15 | $61.00K derived: sum of 3 quarters · filed 2015-04-15 | $82.00K 10-Q/A · filed 2015-04-15 | |||||
| 2013-09-30 | $21.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15 | $45.00K derived: sum of 2 quarters · filed 2015-04-15 | $66.00K 10-Q/A · filed 2015-04-15 | ||||||
| 2013-06-30 | $24.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-04-15 | $45.00K 10-Q/A · filed 2015-04-15 | |||||||
| 2013-03-31 | $21.00K 10-Q/A · filed 2015-04-15 | $24.00K 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |